Detection of Minimal Residual Leukemia Predicts the Outcome of...

Abstract 1453 BackgroundCombination of the hyperCVAD regimen and imatinib or dasatinib has produced long-term leukemia free responses in patients with Philadelphia chromosome positive acute lymphoblastic leukemia even without an allogeneic stem cell transplant.

http://ift.tt/1l58Qsl